These findings suggest that fatty acid metabolism is more vigorous in HER2-positive breast cancer, and elevated fatty acid metabolic pathway is a consistent trait in HER2-positive breast cancer cells and tissues that are resistant to anti-HER2 treatment. Here, ERBB2 is linked to breast carcinoma.